EN | UA
EN | UA

Help Support

Back

Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study

Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study
Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study

To investigate risk factors for postherpetic neuralgia, the neuropathic pain that commonly follows herpes zoster.

See All

Key take away

Postherpetic neuralgia is one of the frequent complications of herpes zoster which may provoke intense pain. The possible risk factors have been potentially explored in this study. The most notable of these risks was the regulation of immunosuppression with the age.

Background

To investigate risk factors for postherpetic neuralgia, the neuropathic pain that commonly follows herpes zoster.

Method

Using primary care data from the Clinical Practice Research Datalink, we fitted multivariable logistic regression models to investigate potential risk factors for postherpetic neuralgia (defined as pain $90 days after zoster, based on diagnostic or prescription codes), including demographic characteristics, comorbidities, and characteristics of the acute zoster episode. We also assessed whether the effects were modified by antiviral use.

Result

Of 119,413 zoster patients, 6,956 (5.8%) developed postherpetic neuralgia. Postherpetic neuralgia risk rose steeply with age, most sharply between 50 and 79 years (adjusted odds ratio [OR] for a 10-year increase, 1.70, 99% confidence interval 1.63–1.78). Postherpetic neuralgia risk was higher in women (6.3% vs 5.1% in men: OR 1.19, 1.10–1.27) and those with severely immunosuppressive conditions, including leukemia (13.7%: 2.07, 1.08–3.96) and lymphoma (12.7%: 2.45, 1.53–3.92); autoimmune conditions, including rheumatoid arthritis (9.1%: 1.20, 0.99–1.46); and other comorbidities, including asthma and diabetes. Current and ex-smokers, as well as underweight and obese individuals, were at increased risk of postherpetic neuralgia. Antiviral use was not associated with postherpetic neuralgia (OR 1.04, 0.97–1.11). However, the increased risk associated with severe immunosuppression appeared less pronounced in patients given antivirals.

Conclusion

Postherpetic neuralgia risk was increased for a number of patient characteristics and comorbidities, notably with age and among those with severe immunosuppression. As zoster vaccination is contraindicated for patients with severe immunosuppression, strategies to prevent zoster in these patients, which could include the new subunit zoster vaccine, are an increasing priority.

Source:

Neurology

Article:

Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study

Authors:

Harriet J. Forbes et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: